| |
KEYNOTE PRESENTERS
 |
Richard T. Moore Senator D-Massachusetts |
 |
Rudolf Jaenisch, Ph.D. Founding Member, Whitehead Institute; Professor of Biology Massachusetts Institute of Technology (MIT) |
 |
Malcolm Moos, M.D., Ph.D. Medical Officer, Division of Cellular and Gene Therapies Food and Drug Administration (FDA) |
 |
Samuel H. Wood CEO Stemagen |
DISTINGUISHED PRESENTERS
Basem M. Abdallah, Ph.D. Associate Professor, Molecular Endocrinology Laboratory (KMEB) Odense University Hospital
Anne Bang, Ph.D. Associate Director, Stem Cell Technologies Novocell
Miriam Bibel, Ph.D. Senior Research Investigator / Project Team Head, Neurodegeneration Novartis
Petter Björquist, Ph.D. Senior Principal Scientist / Project Manager Cellartis
Caifu Chen, Ph.D. Director, Gene Expression &a
|
|